My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

8.050 -0.210 (-2.54%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

31 32 Next >

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today ↗

April 22, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87

Via Benzinga

Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29

Via Benzinga

Psychedelic Stock Gainers And Losers From April 20, 2022 ↗

April 20, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:

Via Benzinga

Compass Pathways Partners With One Mind To Fund Rising Star Awards ↗

April 20, 2022

Compass Pathways plc (NASDAQ:CMPS) and California-based non-profit organization One Mind partnered to sponsor three “2022 One Mind - COMPASS Rising Stars Awards.”

Via Benzinga

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

April 19, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33

Via Benzinga

EXCLUSIVE: ATAI Life Sciences Deploys Decentralized Approach To Transform Mental Health Treatments ↗

April 19, 2022

ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments.

Via Benzinga

EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments ↗

April 19, 2022

For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging...

Via Benzinga

EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge ↗

April 19, 2022

The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.

Via Benzinga

Psychedelic Stock Gainers And Losers From April 18, 2022 ↗

April 18, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28

Via Benzinga

Psychedelic Stock Gainers And Losers From April 14, 2022 ↗

April 14, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32

Via Benzinga

Psychedelic Stock Gainers And Losers From April 13, 2022 ↗

April 13, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.41% at $0.24

Via Benzinga

Why Psychedelics Could Soon Replace Antidepressants

April 13, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From April 11, 2022 ↗

April 11, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17

Via Benzinga

Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗

April 08, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16

Via Benzinga

Christian Angermayer Buys 1 Million Shares Of Atai Life, His Own Company ↗

April 08, 2022

Christian Angermayer, founder and chairman of Atai Life Sciences (Nasdaq: ATAI), told Twitter that he bought 1 million shares of his ...

Via Benzinga

Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 07, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14

Via Benzinga

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 06, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From April 5, 2022 ↗

April 05, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS:

Via Benzinga

Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 04, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18

Via Benzinga

Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity? ↗

April 04, 2022

Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into...

Via Benzinga

Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

April 01, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86

Via Benzinga

March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19% ↗

April 01, 2022

An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the...

Via Talk Markets

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

March 31, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27

Via Benzinga

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

March 30, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46

Via Benzinga

atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results ↗

March 30, 2022

atai Life Sciences N.V. (NASDAQ: ATAI) has announced its financial results for the fourth quarter and full year ended December 31, ...

Via Benzinga

Demand for Toad Venom Rises Along With the Booming Psychedelics Market

March 30, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From March 29, 2022 ↗

March 29, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42

Via Benzinga

Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space ↗

March 29, 2022

The psychedelics legislative landscape continues to move forward with Hazel Park,Michiganenacting decriminalization ...

Via Benzinga

Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today ↗

March 28, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.